Greg A. Onyszchuk, PhD

Ask me about: FDA requirements, New Drug Application (NDA) submissions

Greg Onyszchuk develops business strategy and leads organic and inorganic growth initiatives, including business partnerships and new service development. He has worked in the technology and life sciences industries for more than 30 years, holding roles of increasing responsibility in engineering, product development, product management, marketing, operations, business development and general management. Dr. Onyszchuk is a nationally-recognized expert in FDA requirements for electronic submission formats and has extensive experience in planning and program management of New Drug Application (NDA) submissions.